Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02905929 · ClinicalTrials.gov registry record · NA
Trial to Reduce Sitting Time in Postmenopausal Latina Women at Increased Risk for Heart Disease
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 254
- Enrollment target
NCT02905929: Completed NA study, sponsored by University of California, San Diego.
NCT02905929 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 254 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02905929, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 254 participants
- Enrollment target
Study Summary
Project 2 of the University of California, San Diego (UCSD) American Heart Association (AHA) Women's Health Program will assess 3-month changes in sitting time, standing time, physical activity and blood pressure in a randomized control trial (RCT). This 2-arm RCT will occur in the community with post menopausal Latina women (N=250) who spend at least 8 hrs/day sitting and have increased risk for cardiovascular disease through high BMI and other cardiometabolic risk factors. Women will be identified through the San Ysidro Health Center and assessed at the South Bay Latino Research Center.
Primary Outcome
Change in daily time spent sitting, standing and stepping during waking hours as measured objectively by the ActivPAL
Interventions
- DEVICE ActivPAL inclinometer
- BEHAVIORAL Phone counseling call: Breaking up sitting time
- BEHAVIORAL In-person counseling: Breaking up sitting time
- BEHAVIORAL Phone counseling call: Healthy living
- OTHER Tools to prompt standing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 254 participants |
| Start Date | 2017-04-01 |
| Est. Completion | 2022-03-30 |
| Phase | NA |
What the finished NCT02905929 record still lists
NCT02905929 is an interventional study that assigns participants to a tested intervention. The registered 254 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 5 interventions - of which ActivPAL inclinometer is the first listed.
NCT02905929 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02905929 about?
NCT02905929 is a clinical study titled "Trial to Reduce Sitting Time in Postmenopausal Latina Women at Increased Risk for Heart Disease". Project 2 of the University of California, San Diego (UCSD) American Heart Association (AHA) Women's Health Program will assess 3-month changes in sitting time, standing time, physical activity and blood pressure in a randomized control trial (RCT). This 2-arm RCT will occur in the community with po...
What is the current status of trial NCT02905929?
This trial is currently completed. It is a NA study. The enrollment target is 254 participants. The study started on 2017-04-01. Estimated completion is 2022-03-30.
What interventions are being tested in trial NCT02905929?
The interventions under investigation include: ActivPAL inclinometer (DEVICE), Phone counseling call: Breaking up sitting time (BEHAVIORAL), In-person counseling: Breaking up sitting time (BEHAVIORAL), Phone counseling call: Healthy living (BEHAVIORAL), Tools to prompt standing (OTHER).
Who is sponsoring clinical trial NCT02905929?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02905929's enrollment target sits among peer trials
254 407th of 2000 higher than 1,594 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04390737 · 254 participants · Phase 1
Evaluate the Safety and Clinical Activity of HH2853
- NCT04677647 · 254 participants · NA
OurChild: A Health IT Solution to Reduce Minority Health Disparities
- NCT05503797 · 254 participants · Phase 2
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- NCT06167317 · 254 participants · Phase 1
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI